Breaking News, Financial News

Financial Report: AMRI

Revenues up 19% in the quarter

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

AMRI   2Q Revenues: $59.3 million (+19%) 2Q Loss: $2.2 million (earnings were $297k in 2Q12) YTD Revenues: $118.7 million (+14%) YTD Earnings: $4.3 million (loss of $3.6 million YTD12) Comments: Contract revenue for the quarter was $50.8 million, up 20%, with Discovery Services revenue up 26% to $10.8 million; Development/Small Scale Manufacturing revenue up 7% to $8.7 million; and Large Scale Manufacturing revenue up 22% to $31.3 million. Royalty revenue in the quarter was $8.5 million, up ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters